Telik Regains Compliance With Minimum Bid Price Requirement

  //health-fitness.news-articles.net/content/2012/ .. mpliance-with-minimum-bid-price-requirement.html
  Published in Health and Fitness on Tuesday, April 17th 2012 at 14:11 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

Telik Regains Compliance With Minimum Bid Price Requirement -- PALO ALTO, Calif., April 17, 2012 /PRNewswire/ --

[ ]

My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about TELK

PALO ALTO, Calif., April 17, 2012 /PRNewswire/ -- Telik, Inc. (Nasdaq: [ TELK ]) today announced that it has received from The Nasdaq Stock Market notification that Telik has regained compliance with the minimum bid price rule for continued listing on The Nasdaq Capital Market because the bid price of Telik's common stock has closed at $1.00 per share or greater for at least 10 consecutive business days.

About Telik

Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and developing small molecule drugs to treat cancer.  The company's most advanced drug candidate is Telintra®, a modified glutathione analog intended for the treatment of hematologic disorders including myelodysplastic syndrome; followed by Telcyta®, a cancer activated drug for the treatment of a variety of cancers.  Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP®, which enables the rapid and efficient discovery of small molecule drug candidates.  Additional information is available at [ www.telik.com ].

TELIK, the Telik logo, TELINTRA, TELCYTA, and TRAP are trademarks or registered trademarks of Telik, Inc.

SOURCE Telik, Inc.

RELATED LINKS
[ http://www.telik.com ]